Table 1 Baseline patient characteristics
Characteristics | No (%) (n = 28) |
|---|---|
Age, median (range), years | 56.5 (41.0–81.0) |
Sex | Â |
 Male | 12 (42.9%) |
 Female | 16 (57.1%) |
BMI, mean (SD), kg/m2 | 23.1 (4.3) |
ECOG performance status | Â |
 0 | 24 (85.7%) |
 1 | 4 (14.3%) |
Regorafenib therapy | Â |
 3rd line | 10 (35.7%) |
 4th line | 9 (32.1%) |
 5th line | 7 (25.0%) |
 ≥ 6th line | 2 (7.1%) |
Skin lesions before study commencement | Â |
 None | 12 (42.9%) |
 Present | 16 (57.1%) |
  Tinea | 3 (10.7%) |
  Eczema | 5 (17.8%) |
  Corn/clavus | 8 (28.6%) |
  Other (e.g., hyperkeratosis) | 6 (21.4%) |